Development of Kidney Disease in Type-2-Diabetes; High Risk in Adolescent Diabetes-Manifestation

被引：0

作者：

Jecht, M. ^{[1
]}

机构：

[1] GK Havelhohe, D-14089 Berlin, Germany

来源：

DIABETOLOGE | 2012年 / 8卷 / 05期

关键词：

STAGE RENAL-DISEASE; TYPE-2; YOUTH; PREVALENCE; MELLITUS;

D O I：

10.1007/s11428-012-0935-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：407 / 408

页数：2

共 50 条

[31] Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
Pliquett, R. U.
Fasshauer, M.
Blueher, M.
Paschke, R.
[J]. CARDIOVASCULAR DIABETOLOGY, 2004, 3 (1)
[32] Type-2-Diabetes - Aliskiren promises high nephroprotective potential
不详
[J]. HERZ, 2007, 32 (08) : A17 - A18
[33] Ipragliflozin for the Treatment of Fatty Liver Disease in Type-2-Diabetes
Kahl, S.
[J]. DIABETOLOGE, 2022, 18 (01): : 67 - 68
[34] Early detection of Type-2-Diabetes
不详
[J]. DIABETES STOFFWECHSEL UND HERZ, 2019, 28 (03): : 156 - 156
[35] Type-2-Diabetes Disease Management Guidelines can be commented
不详
[J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (31-32): : A1518 - A1518
[36] Customized treatment of Type-2-Diabetes
不详
[J]. DIABETES STOFFWECHSEL UND HERZ, 2017, 26 (05): : 277 - 278
[37] News about Type-2-Diabetes
Mehnert, Hellmut
[J]. DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 (02) : 149 - 150
[38] Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
RU Pliquett
M Fasshauer
M Blüher
R Paschke
[J]. Cardiovascular Diabetology, 3
[39] Type-2-diabetes in children and adolescents
Holl, RW
Wabitsch, M
Heinze, E
[J]. MONATSSCHRIFT KINDERHEILKUNDE, 2001, 149 (07) : 660 - 669
[40] Therapy for Patients with Type-2-Diabetes
Landgraf, Ruediger
Aberle, Jens
Birkenfeld, Andreas L.
Gallwitz, Baptist
Kellerer, Monika
Klein, Harald H.
Mueller-Wieland, Dirk
Nauck, Michael A.
Reuter, Hans-Martin
Siegel, Erhard
[J]. DIABETOLOGIE UND STOFFWECHSEL, 2020, 15 : S65 - S92